| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 1999;68:2074-2080
© 1999 The Society of Thoracic Surgeons
a Division of Cardiovascular Surgery, Department of Surgery, The Toronto Hospital, University of Toronto, Toronto, Ontario, Canada
Address reprint requests to Dr Li, General Division, The Toronto Hospital, CCRW 1-815, 101 College St, Toronto, ON, Canada M5G 2C4;
e-mail: rli{at}torhosp.toronto.on.ca
Presented at the Thirty-fifth Annual Meeting of The Society of Thoracic Surgeons, San Antonio, TX, Jan 25–27, 1999.
Background. Fetal ventricular cardiomyocyte transplantation into a cardiac scar improved ventricular function, but these cells were eventually eliminated by rejection. We therefore examined the feasibility of autologous adult heart cell transplantation.
Methods. A transmural scar was produced in the left ventricular free wall of adult rats by cryoinjury. The left atrial appendage was harvested, and the atrial heart cells were cultured and their number expanded ex vivo. Three weeks after cryoinjury, either a cell suspension (2 x 106 cells, n = 12 rats, transplant group) or culture medium (n = 10 rats, control group) was injected into the scar. Rats having a sham operation (n = 5) did not undergo cryoinjury or transplantation with cells or culture medium.
Results. Five weeks after injection, ventricular function was evaluated in a Langendorff preparation, measuring systolic, diastolic, and developed pressures over a range of intraventricular balloon volumes. Systolic and developed pressures were greater in the transplant group than in the control group (p = 0.0001). Rats with a sham operation had the greatest systolic, diastolic, and developed pressures (p = 0.0001). Histologic studies demonstrated survival of the transplanted heart cells within the scar. The area of the scar was smaller (p = 0.0003) and its thickness greater (p = 0.0003) in rats in the transplant group. Left ventricular chamber volume was smaller in the transplant group (p = 0.043).
Conclusions. Transplantation of autologous cultured adult atrial heart cells limited scar thinning and dilatation and improved myocardial function compared with results in control hearts. This technique may lead to a novel therapy to prevent scar expansion after a myocardial infarction and prevent the development of congestive heart failure.
This article has been cited by other articles:
|
|
 |
|
  J.-Y. Min, X. Huang, M. Xiang, A. Meissner, Y. Chen, Q. Ke, E. Kaplan, J. S. Rana, P. Oettgen, and J. P. Morgan Homing of intravenously infused embryonic stem cell-derived cells to injured hearts after myocardial infarction J. Thorac. Cardiovasc. Surg., April 1, 2006; 131(4): 889 - 897. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B.-O. Kim, H. Tian, K. Prasongsukarn, J. Wu, D. Angoulvant, S. Wnendt, A. Muhs, D. Spitkovsky, and R.-K. Li Cell Transplantation Improves Ventricular Function After a Myocardial Infarction: A Preclinical Study of Human Unrestricted Somatic Stem Cells in a Porcine Model Circulation, August 30, 2005; 112(9_suppl): I-96 - I-104. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Siminiak, D. Fiszer, O. Jerzykowska, B. Grygielska, N. Rozwadowska, P. Kalmucki, and M. Kurpisz Percutaneous trans-coronary-venous transplantation of autologous skeletal myoblasts in the treatment of post-infarction myocardial contractility impairment: the POZNAN trial Eur. Heart J., June 2, 2005; 26(12): 1188 - 1195. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. DOLNIKOV, M. SHILKRUT, N. ZEEVI-LEVIN, A. DANON, S. GERECHT-NIR, J. ITSKOVITZ-ELDOR, and O. BINAH Functional Properties of Human Embryonic Stem Cell-Derived Cardiomyocytes Ann. N.Y. Acad. Sci., June 1, 2005; 1047(1): 66 - 75. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kofidis, J. L. de Bruin, T. Yamane, M. Tanaka, D. R. Lebl, R.-J. Swijnenburg, I. L. Weissman, and R. C. Robbins Stimulation of Paracrine Pathways With Growth Factors Enhances Embryonic Stem Cell Engraftment and Host-Specific Differentiation in the Heart After Ischemic Myocardial Injury Circulation, May 17, 2005; 111(19): 2486 - 2493. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Hattan, H. Kawaguchi, K. Ando, E. Kuwabara, J. Fujita, M. Murata, M. Suematsu, H. Mori, and K. Fukuda Purified cardiomyocytes from bone marrow mesenchymal stem cells produce stable intracardiac grafts in mice Cardiovasc Res, February 1, 2005; 65(2): 334 - 344. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Schuh, S. Breuer, R. Al Dashti, N. Sulemanjee, P. Hanrath, C. Weber, B. F. Uretsky, and E. R. Schwarz Administration of Vascular Endothelial Growth Factor Adjunctive to Fetal Cardiomyocyte Transplantation and Improvement of Cardiac Function in the Rat Model Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2005; 10(1): 55 - 66. [Abstract] [PDF]
|
|
|
|
 |
|
 T. Kofidis, J. L. de Bruin, T. Yamane, L. B. Balsam, D. R. Lebl, R.-J. Swijnenburg, M. Tanaka, I. L. Weissman, and R. C. Robbins Insulin-Like Growth Factor Promotes Engraftment, Differentiation, and Functional Improvement after Transfer of Embryonic Stem Cells for Myocardial Restoration Stem Cells, December 1, 2004; 22(7): 1239 - 1245. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.H. Grinnemo, A. Mansson, G. Dellgren, D. Klingberg, E. Wardell, V. Drvota, C. Tammik, J. Holgersson, O. Ringden, C. Sylven, et al. Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium J. Thorac. Cardiovasc. Surg., May 1, 2004; 127(5): 1293 - 1300. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Fujii, T. M. Yau, R. D. Weisel, N. Ohno, D. A. G. Mickle, N. Shiono, T. Ozawa, K. Matsubayashi, and R.-K. Li Cell transplantation to prevent heart failure: a comparison of cell types Ann. Thorac. Surg., December 1, 2003; 76(6): 2062 - 2070. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Weikert, M. Eppenberger-Eberhardt, and H. M Eppenberger Cellular engineering of ventricular adult rat cardiomyocytes Cardiovasc Res, October 1, 2003; 59(4): 874 - 882. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Rangappa, J. W. C. Entwistle, A. S. Wechsler, and J. Y. Kresh Cardiomyocyte-mediated contact programs human mesenchymal stem cells to express cardiogenic phenotype J. Thorac. Cardiovasc. Surg., July 1, 2003; 126(1): 124 - 132. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. H.L. Tang, P. W.M. Fedak, T. M. Yau, R. D. Weisel, A. Kulik, D. A.G. Mickle, and R.-K. Li Cell transplantation to improve ventricular function in the failing heart Eur. J. Cardiothorac. Surg., June 1, 2003; 23(6): 907 - 916. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Dowell, M. Rubart, K. B.S. Pasumarthi, M. H. Soonpaa, and L. J. Field Myocyte and myogenic stem cell transplantation in the heart Cardiovasc Res, May 1, 2003; 58(2): 336 - 350. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. O. Al-Radi, V. Rao, R.-k. Li, T. Yau, and R. D. Weisel Cardiac cell transplantation: closer to bedside Ann. Thorac. Surg., February 1, 2003; 75(2): S674 - 677. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-Y. Min, M. F. Sullivan, Y. Yang, J.-P. Zhang, K. L. Converso, J. P. Morgan, and Y.-F. Xiao Significant improvement of heart function by cotransplantation of human mesenchymal stem cells and fetal cardiomyocytes in postinfarcted pigs Ann. Thorac. Surg., November 1, 2002; 74(5): 1568 - 1575. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Xu, S. Police, N. Rao, and M. K. Carpenter Characterization and Enrichment of Cardiomyocytes Derived From Human Embryonic Stem Cells Circ. Res., September 20, 2002; 91(6): 501 - 508. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Sakakibara, K. Tambara, F. Lu, T. Nishina, N. Nagaya, K. Nishimura, and M. Komeda Cardiomyocyte transplantation does not reverse cardiac remodeling in rats with chronic myocardial infarction Ann. Thorac. Surg., July 1, 2002; 74(1): 25 - 30. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Kellar, L. K. Landeen, B. R. Shepherd, G. K. Naughton, A. Ratcliffe, and S. K. Williams Scaffold-Based Three-Dimensional Human Fibroblast Culture Provides a Structural Matrix That Supports Angiogenesis in Infarcted Heart Tissue Circulation, October 23, 2001; 104(17): 2063 - 2068. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Fuchs, B. A. Nasseri, and J. P. Vacanti Tissue engineering: a 21st century solution to surgical reconstruction Ann. Thorac. Surg., August 1, 2001; 72(2): 577 - 591. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Zvara Treatment of Perioperative Myocardial Ischemia Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 2001; 5(2): 166 - 183. [Abstract] [PDF]
|
|
|
|
|
|
R. M. El Oakley, O. C. Ooi, A. Bongso, and M. H. Yacoub Myocyte transplantation for myocardial repair: a few good cells can mend a broken heart Ann. Thorac. Surg., May 1, 2001; 71(5): 1724 - 1733. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Yokomuro, R.-K. Li, D. A. G. Mickle, R. D. Weisel, S. Verma, and T. M. Yau Transplantation of cryopreserved cardiomyocytes J. Thorac. Cardiovasc. Surg., January 1, 2001; 121(1): 0098 - 107. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
